Vivani Medical, Inc. (Nasdaq: VANI) announced the completion of initial dosing for all 20 participants in its SLIM-1 Phase 1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE